Codeine Precipitating Serotonin Syndrome in a Patient in Therapy with Antidepressant and Triptan.
10.9758/cpn.2017.15.3.292
- Author:
Giulia MILANO
1
;
Werner Maria NATTA
;
Alfredo BELLO
;
Antonietta MARTELLI
;
Francesca MATTIOLI
Author Information
1. Department of Internal Medicine, Clinical Pharmacology and Toxicology Unit, University of Genoa, Genoa, Italy. giuliamilano86@yahoo.it
- Publication Type:Case Report
- Keywords:
Drug-drug interactions;
Codeine;
Serotonin syndrome;
Prescription drug misuse;
Migraine disorders;
Major depressive disorder
- MeSH:
Aged;
Anxiety;
Ataxia;
Codeine*;
Depressive Disorder;
Depressive Disorder, Major;
Female;
Humans;
Migraine Disorders;
Neurology;
Pharmacokinetics;
Prescription Drug Misuse;
Pupil;
Reflex;
Reflex, Abnormal;
Serotonin Syndrome*;
Serotonin*;
Tremor;
Venlafaxine Hydrochloride
- From:Clinical Psychopharmacology and Neuroscience
2017;15(3):292-295
- CountryRepublic of Korea
- Language:English
-
Abstract:
The serotonin syndrome is a serioius medical condition due due to an intensive stimulation of setonin receptors. It is a rare, but severe, consequence of interaction between serotomimetic agents. This is a report of a 70-year-old woman steadily in therapy with venlafaxine and rizatriptan for migraine and major depressive syndrome. She was admitted to neurology unit for decreased light reflex with miotic pupils, global hyperreflexia, tremor, anxiety, ataxia and incoordination. The patient was diagnosed as a probable case of serotonin syndrome due to a pharmacological interaction between venlafaxine and rizatriptan trigged by opioid intake. In this paper, the development of syntomatology, the clinical examination and the possible pharmacokinetics explanation were carefully discussed and analysed.
